Laurus Labs Limited

NSE: LAURUSLABS · Healthcare

₹1,866.20
+65.20 (+3.62%)

Last close · 30 Aug 2026, 11:56 am IST

Open
₹1,808.00
Day high
₹1,869.40
Day low
₹1,796.50
Volume
35.51 L
Prev close
₹1,801.00

Price chart

Range
EMA
Also show

Fundamentals

Drug Manufacturers - Specialty & Generic

Valuation

Market Cap
86,505 Cr
Price
1,601.20
P/E (TTM)
79.35
P/E (Fwd)
64.70
P/B
16.31
EV/EBITDA
EV/Revenue
PEG
Div Yield
0.15%
52W High
1,610.00
52W Low
810.05
Beta

Profitability & income

Revenue (TTM)
7,268 Cr
Net Income (TTM)
1,093 Cr
EBITDA
2,040 Cr
Gross Margin
59.44%
Op. Margin
25.72%
Net Margin
15.04%
ROE
16.77%
ROA
8.46%
EPS (TTM)
20.18
EPS (Fwd)
24.75

Financial health

Total Debt
2,518 Cr
Total Cash
113 Cr
Debt/Equity
46.37
Current Ratio
Quick Ratio
Book Value
98.18
Free Cash Flow
554 Cr
Op. Cash Flow
1,624 Cr

Growth

Revenue Growth
29.70%
Earnings Growth
125.20%
Earnings QoQ
125.50%

Quarterly results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-06-302,026 Cr368 Cr647 Cr514 Cr1,270 Cr
2026-03-311,812 Cr279 Cr524 Cr390 Cr1,111 Cr2,518 Cr5,300 Cr
2025-12-311,778 Cr252 Cr486 Cr360 Cr1,084 Cr
2025-06-301,570 Cr163 Cr393 Cr265 Cr932 Cr
2025-03-311,720 Cr234 Cr479 Cr310 Cr938 Cr2,764 Cr4,473 Cr

Annual results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-03-316,721 Cr889 Cr1,823 Cr1,306 Cr3,958 Cr1,624 Cr2,518 Cr5,300 Cr
2025-03-315,508 Cr358 Cr1,121 Cr625 Cr2,968 Cr602 Cr2,764 Cr4,473 Cr
2024-03-315,002 Cr161 Cr793 Cr395 Cr2,503 Cr666 Cr2,577 Cr4,111 Cr
2023-03-316,014 Cr790 Cr1,556 Cr1,294 Cr3,174 Cr994 Cr2,015 Cr4,038 Cr
2022-03-31

Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.

Want charts and signals for LAURUSLABS?

Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.

Sign in
Laurus Labs Limited (LAURUSLABS) share price and fundamentals | TradingJumbo